Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1289 |
---|---|
Product Name | Anti-Human TNFA Recombinant Antibody(Placulumab) |
Molecular Name | Placulumab |
Alias | Anti-TNFA Recombinant Antibody, Research Grade Placulumab |
CAS Number | 945781-29-3 |
Target | TNFA[Homo sapiens] |
Isotype | [V Kappa]2-Fc |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | WB, FCM, IP, ELISA, Neut, FuncS, IF |
Buffer | PBS, pH7.5 |
Background | Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |